STABILIZATION OF 5-AZACYTIDINE BY NUCLEOPHILIC-ADDITION OF BISULFITE ION

被引:14
作者
CHATTERJI, DC
GALLELLI, JF
机构
[1] Pharmaceutical Development Service, Pharmacy Department, Clinical Center, National Institutes of Health., Bethesda, Maryland
基金
美国国家卫生研究院;
关键词
Antineoplastic agents—azacytidine; prodrugs; sodium bisulfite complex; Azacytidine—prodrugs; sodium bisulfite; stabilization in aqueous solutions; effect of pH; Prodrugs—azacytidine; stabilization by sodium bisulfite; Sodium bisulfite—stabilization of azacytidine in aqueous solutions;
D O I
10.1002/jps.2600680709
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
5‐Azacytidine (I) stability was increased approximately 10‐fold over its stability in water or lactated Ringer injection by the addition of excess sodium bisulfite and the maintenance of pH ∼2.5. The increased stability in the presence of bisulfite at pH 2.5 was attributed to the addition of bisulfite across the 5‐6 protonated inline bond of I, which prevented the hydrolytic attack on this labile double bond. However, above pH 4, bisulfite increased I degradation. At higher pH, the compound was no longer protonated and bisulfite did not form the stable addition product. The addition compound quickly decomposed above pH 6 to give back the parent compound and, thus, acted as a I prodrug. The intact drug remaining was assayed by high‐pressure liquid chromatography (HPLC), and the reversibility of the bisulfite‐I addition product above pH 6 was demonstrated by UV spectrophotometry and HPLC. The potential utility of the bisulfite‐I addition product as a I prodrug in parenteral and possible oral dosage forms is discussed. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:822 / 826
页数:5
相关论文
共 13 条
  • [1] SYNTHESIS AND ANTI-TUMOR ACTIVITY OF DIHYDRO-5-AZACYTIDINE, A HYDROLYTICALLY STABLE ANALOG OF 5-AZACYTIDINE
    BEISLER, JA
    ABBASI, MM
    KELLEY, JA
    DRISCOLL, JS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (06) : 806 - 812
  • [2] BEISLER JA, 1976, CANCER TREAT REP, V60, P1671
  • [4] JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P490
  • [5] 5-AZACYTIDINE - NEW ACTIVE AGENT FOR TREATMENT OF ACUTE LEUKEMIA
    KARON, M
    SIEGER, L
    LEIMBROCK, S
    FINKLESTEIN, JZ
    NESBIT, ME
    SWANEY, JJ
    [J]. BLOOD, 1973, 42 (03) : 359 - 365
  • [6] LOMEN PL, 1975, CANCER CHEMOTH REP 1, V59, P1123
  • [7] MCCREDIE KB, 1973, CANCER CHEMOTH REP 1, V57, P319
  • [8] MOERTEL CG, 1972, CANCER CHEMOTH REP 1, V56, P649
  • [9] KINETICS AND MECHANISMS OF DEGRADATION OF ANTILEUKEMIC AGENT 5-AZACYTIDINE IN AQUEOUS-SOLUTIONS
    NOTARI, RE
    DEYOUNG, JL
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (07) : 1148 - 1157
  • [10] PITHOVA P, 1965, COLLECT CZECH CHEM C, V30, P2801